BRETEC — Bioretec Oy Cashflow Statement
0.000.00%
Last trade - 00:00- €54.79m
- €49.18m
- €4.54m
Annual cashflow statement for Bioretec Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -6.02 | -2.42 | -3.79 | -4.61 |
| Depreciation | |||||
| Non-Cash Items | — | 3.35 | 0.125 | 0.755 | 0.412 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2 | 0.11 | -0.248 | -0.604 | -1.05 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2 | -2.39 | -2.36 | -3.44 | -5.11 |
| Capital Expenditures | — | -0.393 | -0.26 | -0.161 | -0.729 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.121 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.121 | -0.393 | -0.26 | -0.161 | -0.729 |
| Financing Cash Flow Items | 4.33 | -1.79 | -1.51 | -0.775 | -0.531 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.33 | 7.13 | -2.78 | 9.29 | 5.21 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.22 | 4.35 | -5.4 | 5.69 | -0.621 |